MBS2320
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for MBS2320, covering 2017-03-28 to 2025-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA [Phase 2]